The other concern I have is with the CR. There are 1bn shares on issue meaning NOR can issue 250m more, 58m were issued in November so let's say 200m can be issued (after May).
Current best case with 1.5c raises $3m while 1c raises $2m. Maybe they can pump the SP to try and achieve better but with the current cash burn and lack of revenue, added to the FY2018 R&D rebate being largely used already doesn't help the company look healthy to prospective clients wanting security.
I imagine all investors, big or small are a bit nervous!
- Forums
- ASX - By Stock
- NOR
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-44
-
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOR (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.24M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.2¢ | $1.12K | 35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 56249 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 26342 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 56249 | 0.032 |
1 | 100000 | 0.031 |
1 | 13400 | 0.030 |
1 | 96000 | 0.028 |
1 | 180000 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 26342 | 1 |
0.039 | 126001 | 1 |
0.040 | 123849 | 1 |
0.042 | 23833 | 1 |
0.044 | 44101 | 2 |
Last trade - 15.07pm 13/11/2024 (20 minute delay) ? |
Featured News
NOR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online